ITGA7

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Alpha-7 integrin is a protein that in humans is encoded by the ITGA7 gene.[1][2] Alpha-7 integrin is critical for modulating cell-matrix interactions. Alpha-7 integrin is highly expressed in cardiac muscle, skeletal muscle and smooth muscle cells, and localizes to Z-disc and costamere structures. Mutations in ITGA7 have been associated with congenital myopathies and noncompaction cardiomyopathy, and altered expression levels of alpha-7 integrin have been identified in various forms of muscular dystrophy.

Structure

ITGA7 encodes the protein alpha-7 integrin. Alpha-7 integrin is 128.9 kDa in molecular weight and 1181 amino acids in length.[3] Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. Alpha-7 integrin undergoes post-translational cleavage within the extracellular domain to yield disulfide-linked light and heavy chains that join with beta 1 to form an integrin that binds to the extracellular matrix protein laminin-1. The primary binding partners of alpha-7 integrin are laminin-1 (alpha1-beta1-gamma1), laminin-2 (alpha2-beta1-gamma1) and laminin-4 (alpha2-beta2-gamma1).[4] Alpha-7/beta-1 is the major integrin complex expressed in differentiated muscle cells.

Splice variants of alpha-7 integrin that differ in both the extracellular and cytoplasmic domains exist in the mouse[5] and are developmentally regulated in mouse and rat muscle tissue.[5][6][7][8][9] The X1/X2 alternative splicing region lies in the extracellular domain and alters the ligand binding site; specifically, the conserved homology repeat domains 3 and 4.[5] The first identified human transcript contains extracellular and cytoplasmic domains corresponding to the mouse X2 and B variants, respectively. A unique extracellular splice variant was also identified in human.[2][10] The differentially spliced variants detected in rodents have also been detected in humans. Major cytoplasmic, developmentally regulated variants, alpha-7A and alpha-7B, as well as extracellular variants, X1 and X2 were identified in humans. Moreover, the D variant, but not the C variant was detected in humans.[11]

Alpha-7 integrin is highly expressed in striated muscle, namely skeletal and cardiac muscle, and functions as the major laminin-binding integrin.[12] It was later shown that alpha-7 integrin is also highly expressed in smooth muscle.[13] The two major splice variants of alpha-7 integrin appear to have developmentally regulated expression; alpha-7A integrin is expressed solely in skeletal muscle, however alpha-7B integrin is expressed more loosely in striated muscle as well as the vasculature.[14]

Function

The function of alpha-7 integrin, as is the case for most integrins is to mediate cell membrane interactions with extracellular matrix.[15]

The alpha-7/beta-1 integrin complex clearly plays a role in the development of striated muscle and smooth muscle. Alpha-7/beta-1 integrin promotes the adhesion and motility of myoblasts, and is likely important in the recruitment of myogenic precursors during muscle differentiation.[16] It was shown however that beta-1D integrin appears at embryonic day 11 and alpha-7 integrin does not appear until embryonic day 17; thus, beta-1D associates with alternate alpha subunits (alpha-5, alpha-6A) prior to alpha-7.[17] In human skeletal muscle, alpha-7 integrin is also developmentally regulated, being first detected at age 2.[4]

In adult striated muscle cells, alpha-7 integrin (complexed to beta-1 integrin) is localized to Z-discs and costamere structures, bound to the four and one half LIM domain proteins, FHL1 and FHL2.[6][18][19] It has been demonstrated that alpha-7 integrin can be mono-ADP-ribosylated on the cell surface in skeletal muscle cells;[20] however, the functional significance of this modification has not been investigated.

Insights into the function of alpha-7 integrin have come from studies employing mouse transgenesis. A mouse expressing a null allele of the ITGA7 gene are viable, suggesting that alpha-7 integrin is not essential for normal myogenesis; however, these mice develop a phenotype that resembles muscular dystrophy. In soleus muscle, there was a significant disruption of myotendinous junctions, variation in the size of fibers, centrally located nuclei, necrosis, phagocytosis, and elevated serum levels of creatine kinase.[21] It has also been proposed that alpha-7 integrin and gamma-sarcoglycan have overlapping functions in skeletal muscle. In support of this, a double knockout of gamma-sarcoglycan and alpha-7 integrin produced a phenotype that was far worse than either knockout alone. Mice died within 1 month of birth and had severe muscle degeneration, suggesting that the roles of these proteins may overlap to maintain the stability of the sarcolemma.[22] Moreover, the double knockout of dystrophin and alpha-7 integrin produced a Duchenne muscular dystrophy-like phenotype, and demonstrated that alterations in alpha-7 integrin affect the pathological changes observed in dystrophin deficiencies.[23] In support of this notion, AAV overexpression of ITGA7 in skeletal muscle of Duchenne muscular dystrophy (DMD) mice showed a significant protective effect against adverse functional parameters associated with DMD, combined with a reversal of these negative features, suggesting that alpha-7 integrin may be a potential therapeutic candidate to treat Duchenne muscular dystrophy.[24]

Studies employing mutant alpha-7 integrin constructs have shown that the cytoplasmic tail of alpha-7B integrin is essential for regulation of lamellipodia formation and regulation of cell mobility regulation via laminin-1/E8 and p130(CAS)/Crk complex formation.[25]

Clinical Significance

Mutations in ITGA7 have been found in patients with unclassified congenital myopathy.[26] Additionally, in patients with severe congenital fiber type disproportion and left ventricular non-compaction cardiomyopathy, a missense mutation, Glu882Lys, was identified in ITGA7 along with a missense mutation in MYH7B, both novel disease genes having a synergistic effect on disease severity.[27]

Alpha-7B integrin expression has been shown to be significantly decreased at sarcolemmal membranes in patients with laminin alpha2 chain-deficient congenital muscular dystrophy. Additionally, in Duchenne muscular dystrophy and Becker muscular dystrophy, the expression of alpha-7B integrin was enhanced.[4]

Interactions

ITGA7 has been shown to interact with:

See also

References

  1. ↑ Wang W, Wu W, Desai T, Ward DC, Kaufman SJ (Aug 1995). "Localization of the alpha 7 integrin gene (ITGA7) on human chromosome 12q13: clustering of integrin and Hox genes implies parallel evolution of these gene families". Genomics. 26 (3): 568–70. doi:10.1016/0888-7543(95)80176-M. PMID 7607681.
  2. ↑ 2.0 2.1 "Entrez Gene: ITGA7 integrin, alpha 7".
  3. ↑ "Protein sequence of human ITGA7 (Uniprot ID: Q13683)". Cardiac Organellar Protein Atlas Knowledgebase (COPaKB). Retrieved 20 July 2015.
  4. ↑ 4.0 4.1 4.2 Cohn, RD; Mayer, U; Saher, G; Herrmann, R; van der Flier, A; Sonnenberg, A; Sorokin, L; Voit, T (1 March 1999). "Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle". Journal of the neurological sciences. 163 (2): 140–52. doi:10.1016/s0022-510x(99)00012-x. PMID 10371075.
  5. ↑ 5.0 5.1 5.2 Ziober, BL; Vu, MP; Waleh, N; Crawford, J; Lin, CS; Kramer, RH (15 December 1993). "Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development". The Journal of Biological Chemistry. 268 (35): 26773–83. PMID 8253814.
  6. ↑ 6.0 6.1 Maitra, N; Flink, IL; Bahl, JJ; Morkin, E (September 2000). "Expression of alpha and beta integrins during terminal differentiation of cardiomyocytes". Cardiovascular research. 47 (4): 715–25. doi:10.1016/s0008-6363(00)00140-1. PMID 10974220.
  7. ↑ Collo, G; Starr, L; Quaranta, V (5 September 1993). "A new isoform of the laminin receptor integrin alpha 7 beta 1 is developmentally regulated in skeletal muscle". The Journal of Biological Chemistry. 268 (25): 19019–24. PMID 8360188.
  8. ↑ Song, WK; Wang, W; Sato, H; Bielser, DA; Kaufman, SJ (December 1993). "Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases". Journal of Cell Science. 106 (4): 1139–52. PMID 8126096.
  9. ↑ Ziober, BL; Kramer, RH (13 September 1996). "Identification and characterization of the cell type-specific and developmentally regulated alpha7 integrin gene promoter". The Journal of Biological Chemistry. 271 (37): 22915–22. PMID 8798472.
  10. ↑ Leung, E; Lim, SP; Berg, R; Yang, Y; Ni, J; Wang, SX; Krissansen, GW (4 February 1998). "A novel extracellular domain variant of the human integrin alpha 7 subunit generated by alternative intron splicing". Biochemical and Biophysical Research Communications. 243 (1): 317–25. doi:10.1006/bbrc.1998.8092. PMID 9473524.
  11. ↑ Vignier, N; Moghadaszadeh, B; Gary, F; Beckmann, J; Mayer, U; Guicheney, P (5 July 1999). "Structure, genetic localization, and identification of the cardiac and skeletal muscle transcripts of the human integrin alpha7 gene (ITGA7)". Biochemical and Biophysical Research Communications. 260 (2): 357–64. doi:10.1006/bbrc.1999.0916. PMID 10403775.
  12. ↑ Kaufman, SJ; Foster, RF; Haye, KR; Faiman, LE (June 1985). "Expression of a developmentally regulated antigen on the surface of skeletal and cardiac muscle cells". The Journal of Cell Biology. 100 (6): 1977–87. doi:10.1083/jcb.100.6.1977. PMC 2113591. PMID 3889014.
  13. ↑ Yao, CC; Breuss, J; Pytela, R; Kramer, RH (July 1997). "Functional expression of the alpha 7 integrin receptor in differentiated smooth muscle cells". Journal of Cell Science. 110 (13): 1477–87. PMID 9224765.
  14. ↑ Velling, T; Collo, G; Sorokin, L; Durbeej, M; Zhang, H; Gullberg, D (December 1996). "Distinct alpha 7A beta 1 and alpha 7B beta 1 integrin expression patterns during mouse development: alpha 7A is restricted to skeletal muscle but alpha 7B is expressed in striated muscle, vasculature, and nervous system". Developmental Dynamics. 207 (4): 355–71. doi:10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G. PMID 8950511.
  15. ↑ Hynes, RO (3 April 1992). "Integrins: versatility, modulation, and signaling in cell adhesion". Cell. 69 (1): 11–25. doi:10.1016/0092-8674(92)90115-s. PMID 1555235.
  16. ↑ Yao, CC; Ziober, BL; Sutherland, AE; Mendrick, DL; Kramer, RH (December 1996). "Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor". Journal of Cell Science. 109 (13): 3139–50. PMID 9004048.
  17. ↑ Brancaccio, M; Cabodi, S; Belkin, AM; Collo, G; Koteliansky, VE; Tomatis, D; Altruda, F; Silengo, L; Tarone, G (March 1998). "Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development". Cell adhesion and communication. 5 (3): 193–205. doi:10.3109/15419069809040291. PMID 9686317.
  18. ↑ Samson, T; Smyth, N; Janetzky, S; Wendler, O; Müller, JM; Schüle, R; von der Mark, H; von der Mark, K; Wixler, V (2 July 2004). "The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor". The Journal of Biological Chemistry. 279 (27): 28641–52. doi:10.1074/jbc.m312894200. PMID 15117962.
  19. ↑ Galie, PA; Khalid, N; Carnahan, KE; Westfall, MV; Stegemann, JP (NaN). "Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes". Cardiovascular Pathology. 22 (3): 219–27. doi:10.1016/j.carpath.2012.10.003. PMC 3610795. PMID 23266222. Check date values in: |date= (help)
  20. ↑ Zolkiewska, A; Moss, J (1997). "The alpha 7 integrin as a target protein for cell surface mono-ADP-ribosylation in muscle cells". Advances in experimental medicine and biology. 419: 297–303. PMID 9193669.
  21. ↑ Mayer, U; Saher, G; Fässler, R; Bornemann, A; Echtermeyer, F; von der Mark, H; Miosge, N; Pöschl, E; von der Mark, K (November 1997). "Absence of integrin alpha 7 causes a novel form of muscular dystrophy". Nature Genetics. 17 (3): 318–23. doi:10.1038/ng1197-318. PMID 9354797.
  22. ↑ Allikian, MJ; Hack, AA; Mewborn, S; Mayer, U; McNally, EM (1 August 2004). "Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle". Journal of Cell Science. 117 (Pt 17): 3821–30. doi:10.1242/jcs.01234. PMID 15252120.
  23. ↑ Guo, C; Willem, M; Werner, A; Raivich, G; Emerson, M; Neyses, L; Mayer, U (15 March 2006). "Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy". Human Molecular Genetics. 15 (6): 989–98. doi:10.1093/hmg/ddl018. PMID 16476707.
  24. ↑ Heller, KN; Montgomery, CL; Janssen, PM; Clark, KR; Mendell, JR; Rodino-Klapac, LR (March 2013). "AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice". Molecular Therapy. 21 (3): 520–5. doi:10.1038/mt.2012.281. PMC 3589167. PMID 23319059.
  25. ↑ Mielenz, D; Hapke, S; Pöschl, E; von Der Mark, H; von Der Mark, K (20 April 2001). "The integrin alpha 7 cytoplasmic domain regulates cell migration, lamellipodia formation, and p130CAS/Crk coupling". The Journal of Biological Chemistry. 276 (16): 13417–26. doi:10.1074/jbc.m011481200. PMID 11278916.
  26. ↑ Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K (May 1998). "Mutations in the integrin alpha7 gene cause congenital myopathy". Nature Genetics. 19 (1): 94–7. doi:10.1038/ng0598-94. PMID 9590299.
  27. ↑ Esposito, T; Sampaolo, S; Limongelli, G; Varone, A; Formicola, D; Diodato, D; Farina, O; Napolitano, F; Pacileo, G; Gianfrancesco, F; Di Iorio, G (21 June 2013). "Digenic mutational inheritance of the integrin alpha 7 and the myosin heavy chain 7B genes causes congenital myopathy with left ventricular non-compact cardiomyopathy". Orphanet journal of rare diseases. 8: 91. doi:10.1186/1750-1172-8-91. PMC 3695851. PMID 23800289.
  28. ↑ Vachon, PH; Xu, H; Liu, L; Loechel, F; Hayashi, Y; Arahata, K; Reed, JC; Wewer, UM; Engvall, E (1 October 1997). "Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy". The Journal of Clinical Investigation. 100 (7): 1870–81. doi:10.1172/jci119716. PMC 508374. PMID 9312189.
  29. ↑ Hodges, BL; Hayashi, YK; Nonaka, I; Wang, W; Arahata, K; Kaufman, SJ (November 1997). "Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies". Journal of Cell Science. 110 (22): 2873–81. PMID 9427295.
  30. ↑ Vachon, PH; Xu, H; Liu, L; Loechel, F; Hayashi, Y; Arahata, K; Reed, JC; Wewer, UM; Engvall, E (1 October 1997). "Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy". The Journal of Clinical Investigation. 100 (7): 1870–81. doi:10.1172/jci119716. PMC 508374. PMID 9312189.
  31. ↑ 31.0 31.1 Samson T, Smyth N, Janetzky S, Wendler O, Müller JM, Schüle R, von der Mark H, von der Mark K, Wixler V (Jul 2004). "The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor". J. Biol. Chem. 279 (27): 28641–52. doi:10.1074/jbc.M312894200. PMID 15117962.

Further reading

External links

Retrieved from "https://www.wikidoc.org/index.php?title=ITGA7&oldid=1415705"